Applied Genetic Technologies (AGTC) Tops Q4 EPS by 8c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q4 EPS of $0.15, $0.08 better than the analyst estimate of $0.07. Revenue for the quarter came in at $12.1 million versus the consensus estimate of $12.93 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits